Univest
Univest
  • Markets

Sarda Proteins Ltd. Hits Lower Circuit on BSE, 28 October 2026

  • September 25, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Sarda Proteins lower circuit today on BSE

Sarda Proteins Ltd. (FRESITA) could not trade below Rs 136.6 on BSE on 28 October 2026, because that was where the exchange price band cut off the day’s fall. The Sarda Proteins lower circuit sits 1.97% under the previous close of Rs 139.35, and the stock was locked at that floor at the time of writing.

Market cap is Rs 125.08 crore, and it was the third session in a row at the band, a detail short-term market participants will track.

Table of Contents

Toggle
  • Key Takeaways
  • Key Market Data
  • Price Action and Trading Activity
  • Why Sarda Proteins Ltd. Hit Lower Circuit
  • What the Sarda Proteins Lower Circuit Means
  • Sarda Proteins Ltd. Fundamentals and Valuation
  • Peer and Sector Context
  • Technical Snapshot
  • What Readers Should Know
  • Frequently Asked Questions
    • Why did Sarda Proteins Ltd. hit lower circuit on 28 October 2026?
    • What was Sarda Proteins Ltd. share price on 28 October 2026?
    • What was the lower circuit price for Sarda Proteins Ltd.?
    • What is Sarda Proteins Ltd.’s market cap and PE ratio?
    • Which exchange and data source were used?
    • Does hitting a lower circuit mean Sarda Proteins Ltd. is a buy or a sell?
    • Can you buy or sell Sarda Proteins Ltd. shares when the stock is at the lower circuit?
    • What happens the next trading session after a lower circuit?
    • What is the lower circuit limit set at for Indian stocks?

Key Takeaways

  • Sarda Proteins Ltd. hit the lower circuit on BSE at Rs 136.6 on 28 October 2026.
  • The session move was -1.97% against a previous close of Rs 139.35.
  • Market capitalisation stood at Rs 125.08 crore with a PE ratio of 47.52.
  • No official company announcement or verified catalyst was confirmed at the time of writing.
  • A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

Metric Value
Stock Sarda Proteins Ltd.
Current Price / LTP Rs 136.6
Day Move -1.97%
Previous Close Rs 139.35
Day Open Rs 136.6
Day High Rs 136.6
Day Low Rs 136.6
Lower Circuit Price Rs 136.6
Lower Circuit Limit Rs 136.6
Market Cap Rs 125.08 crore
Selected Exchange BSE
PE Ratio 47.52

All figures above are as of 28 October 2026, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

Sarda Proteins Ltd. opened at Rs 136.6 on BSE, below the previous close of Rs 139.35, and the high, low and last price of the day all stayed at that figure. The price therefore met the band limit at the open and never moved off it.

The decline was Rs 2.75, or -1.97%. Because the stock never left the band, there is no intraday range to report, and every number is drawn from BSE alone.

Price bands and previous-close values can vary between exchanges, so the report sticks to one. The limit for the session was Rs 136.6, the level the stock stayed at.

Why Sarda Proteins Ltd. Hit Lower Circuit

Selling pressure took Sarda Proteins Ltd. down to the exchange-defined price band, which then stopped further decline. No official company announcement or verified external catalyst had been confirmed at the time of writing, so price action and market sentiment are the available lens.

No confirmed trigger can be named, so this article stays away from earnings, a corporate action, sector news and market rumours as explanations. A confirmed announcement, if one emerges, would be handled in a separate update.

Rs 136.6 was the lower circuit level the stock reached during the session.

What the Sarda Proteins Lower Circuit Means

A lower circuit is the price floor an exchange band imposes on a stock for the session. For Sarda Proteins Ltd., the floor in effect was Rs 136.6 on 28 October 2026.

The point of a band is to slow big moves and preserve orderly trading, so it is a rule of market structure and not a return forecast. In this note the circuit records what took place in the session and where the band was reached.

Sarda Proteins Ltd. Fundamentals and Valuation

Market data adds substance behind the price move. Sarda Proteins Ltd. has a PE ratio of 47.52 and a PB ratio of 1.44, with book value of Rs 97.03, EPS of 2.93 and a market cap of Rs 125.08 crore. These are descriptive figures, not a buy, sell or hold view.

A PB ratio of 1.44 puts the share price modestly above reported book value per share. A premium that size could reflect growth expectations or asset quality, though thin trading in a smaller counter can have the same effect.

Readers tracking lower circuit events can use these ratios to keep the price event apart from the company’s wider financial profile. One sharp session gets attention, but valuation and returns have to be reviewed separately.

Peer and Sector Context

Sarda Proteins Ltd. belongs to the Trading industry. The peer table below uses available companies from the same sector or industry to give broader valuation context.

Peer Company Market Cap PE PB ROE
Confidence Petroleum India Ltd. Rs 2306.09 crore 17.13 1.57 7%
Vintage Coffee & Beverages Ltd. Rs 2263.25 crore 28.74 4.02 17.91%
Aayush Art And Bullion Ltd. Rs 2013.63 crore 255.16 33.13 13.89%
Khazanchi Jewellers Ltd. Rs 1794.4 crore 17.58 5.17 32.45%
Fischer Medical Ventures Ltd. Rs 1787.24 crore 59.93 3.84 9.38%

Several of these peers are far larger by market capitalisation than Sarda Proteins Ltd. Size differences change liquidity and cost of capital, so the table is sector context rather than a like-for-like ranking.

Sarda Proteins Ltd.’s PE ratio was 47.52, compared with an available peer PE average of 75.71, calculated from the 5 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Want to know more? Log in to Univest for more stock insights.

Technical Snapshot

The technical snapshot adds context: RSI was 55.33, the 50-day moving average was 145.76 and the 200-day moving average was 95.88.

What Readers Should Know

Established so far: Sarda Proteins Ltd. sat at the lower circuit on BSE at Rs 136.6 on 28 October 2026, a day move of -1.97%.

Once the band is hit, sell orders accumulate at that price while buyers are scarce, so an exit at the quoted price may not be possible. No official catalyst had been confirmed when this was written, which is the other constraint.

A lower circuit is a market update and not a final judgement. It reflects heavy selling at present, and a proper review would weigh business fundamentals, valuation, liquidity, risk and confirmed company disclosures.

Frequently Asked Questions

Why did Sarda Proteins Ltd. hit lower circuit on 28 October 2026?

The stock reached its lower price band after selling pressure during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

What was Sarda Proteins Ltd. share price on 28 October 2026?

The last traded price used in this article was Rs 136.6 on BSE. That price matched the lower circuit price captured for the event.

What was the lower circuit price for Sarda Proteins Ltd.?

The lower circuit price was Rs 136.6. The stated exchange lower circuit limit was Rs 136.6. The event numbers in this article are aligned to BSE.

What is Sarda Proteins Ltd.’s market cap and PE ratio?

Sarda Proteins Ltd.’s market cap was Rs 125.08 crore. PE ratio was 47.52.

Which exchange and data source were used?

The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 28 October 2026.

Does hitting a lower circuit mean Sarda Proteins Ltd. is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Sarda Proteins Ltd. shares when the stock is at the lower circuit?

It is usually difficult. At the lower circuit, sell orders queue up with few buyers, so exiting at the quoted price may not be possible. Orders can stay unfilled until buying interest returns.

What happens the next trading session after a lower circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the lower circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Sarda Proteins Ltd. the stated limit was Rs 136.6. For this session, Sarda Proteins Ltd. moved -1.97%.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply